Molecular imaging with contrast ultrasound and targeted microbubbles

@article{Lindner2004MolecularIW,
  title={Molecular imaging with contrast ultrasound and targeted microbubbles},
  author={J. Lindner},
  journal={Journal of Nuclear Cardiology},
  year={2004},
  volume={11},
  pages={215-221}
}
  • J. Lindner
  • Published 2004
  • Medicine
  • Journal of Nuclear Cardiology
  • There is growing interest in the development of methods for imaging cellular and molecular mediators of cardiovascular diseases. Techniques for imaging molecular and cellular alterations have been explored for essentially all noninvasive cardiac imaging modalities. Molecular imaging with contrast-enhanced ultrasound relies on the detection of novel site-targeted microbubble contrast agents. These microbubbles are retained within regions of a specific disease process, thereby allowing phenotypic… CONTINUE READING
    114 Citations
    Seeing the Invisible-Ultrasound Molecular Imaging.
    • 2
    Contrast Ultrasound and Targeted Microbubbles: Diagnostic and Therapeutic Applications for Angiogenesis
    • 22
    Molecular imaging using contrast-enhanced ultrasound: evaluation of angiogenesis and cell therapy.
    • 42
    • PDF
    Targeted Therapeutic Applications of Acoustically Active Microspheres in the Microcirculation
    • 28
    Encapsulated microbubbles and echogenic liposomes for contrast ultrasound imaging and targeted drug delivery
    • 37
    Microbubble-mediated intravascular ultrasound imaging and drug delivery
    • 11
    Advances in Ultrasound Mediated Gene Therapy Using Microbubble Contrast Agents
    • 136
    • PDF

    References

    SHOWING 1-10 OF 27 REFERENCES
    In vitro studies of a new thrombus-specific ultrasound contrast agent.
    • 144
    Ultrasonic enhancement of α vβ 3 expressing-cells with targeted contrast agents
    • 1
    Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging.
    • Klibanov
    • Medicine
    • Advanced drug delivery reviews
    • 1999
    • 240
    Development of inherently echogenic liposomes as an ultrasonic contrast agent.
    • 166